Are you part of a company facing obstacles when it comes to biosimilars? Don’t let the lack of guidelines or experience with biosimilar development slow you down. Get the information you need to help develop your products from experts and colleagues at the 2nd Biosimilars summit.
Join us to discuss some key insights from thought leaders into the biggest challenges in the analytical and clinical phases of biosimilar drug development, from addressing current regulatory struggles, demonstrating the quality attributes needed to prove interchangeability, and successfully entering the market. For more information download the agenda: http://bit.ly/bprlistagenda
Quality assurance from comparing the originator to the biosmiliar to ensure compatability
Potential ramifications surrounding immunogenicity that might hinder progression
Physician and patient education on the importance and advances of biosimilars
Patient selection and population for your clinical trial to gather data
Brand awareness and marketing strategies for you new biosimilar.